Liposomes have received extensive attention as nanocarriers for bioactive compounds due to their good biocompatibility, possibility of targeting and incorporation of hydrophilic and hydrophobic compounds.
Introduction
The development of nanotechnological solutions for biomedical applications has been a major focus of interest over recent years. New nanocarriers are constantly developed for therapeutic applications, and every year more nanomedicines are approved for human therapy. 1 Nevertheless, potential adverse impact of nanomaterials on human health is yet to be fully understood, 2 and the molecular events involved in nanoparticle toxicity need further in depth studies. While most chemicals are cytotoxic due to interactions with specific biomolecules, one single nanoparticle might induce the production of reactive oxygen species (ROS), morphological alterations, genotoxicity and immunological effects. 3 In fact, parameters, since the high surface area to mass ratio strongly influences interactions with biological molecules such as proteins and cells. Additionally, binding to/interaction with biological molecules alter nanoparticles' surface properties, influencing the interface with the cellular microenvironment. 4 Other variables apart from size such as type of material, shape, surface charge, hydrophobicity or concentration must also be considered. 5 Even though "cytotoxicity of nanoparticles" has been the subject of excellent reviews in recent years, these are generally focused on metallic nanoparticles, quantum dots or carbon nanotubes, whilst liposomes have not been systematically evaluated. [6] [7] [8] The cytotoxicity mechanism of liposomes is usually reported to be surface charge dependent. 9, 10 Liposomes influence several signaling pathways, 11 inducing apoptosis depending on their association with cells and ROS production. 9, 12 Moreover, the type of hydrophobic chain, hydrophilic group and linker also have influence on the cytotoxic response. 9, 13 Although in vitro cell-based testing is a proficient, informative and fairly cost-effective approach to be considered for initial screening of nanotoxicity, 14 it does not replace the high degree of biological organization that in vivo 3D-models represent. Because cell culture systems do not take into consideration the responses at the whole-organism scale, they can lead to misleading conclusions. To date, many studies addressing the in vivo toxicity assessment of nanoparticles are contradictory or have limited scope, mainly due to the unclarity of the regulatory guideline(s), 15 which when combined with the lack of efficient acute/chronic screening protocols and putative standards, limits the preclinical testing of nanotherapeutics. Zebrafish Danio rerio Hamilton 1822 is a small vertebrate (Pisces: Teleostei) model that requires less expensive husbandry and accommodation than do mammals, commonly used for toxicity evaluation. Zebrafish offers genetic, physiological and anatomical resemblance with mammals including the blood brain barrier, endothelial cells and immunogenic responses. 16 Moreover, zebrafish biology has other advantageous characteristics: (i) females have the capability to lay around 200-300 eggs per day every 5-7 days; (ii) equals the longevity and generation time of mice (3-5 months); and (iii) transparent embryos develop promptly into larvae, ex-utero, within 120 hours postfertilization (hpf ) 17, 18 allowing in vivo real-time imaging of ongoing processes and significant reduction of experiment duration. The zebrafish embryo toxicity (ZET) assay has been extensively used for conservative risk assessment of metallic nanoparticles, carbon-based nanostructures and polymers, screening ecological benchmarks. [19] [20] [21] [22] We have previously observed that liposomes and siRNAlipoplexes composed of dioctadecyldimethylammonium bromide or chloride (DODAB/DODAC) : monoolein (MO) induce dissimilar in vitro responses. 23 The counter ion (Cl − or Br − ) of the cationic lipid not only influences the structure, stability and silencing efficiency of siRNA-lipoplexes, but it also seems to affect their cytotoxicity. There are also indications that the fraction cationic/neutral lipid on the liposomal formulation can play a role in cellular responses. Therefore, in the present study, we investigated the influence of the counter ion (Br − or Cl − ) and of the cationic/neutral lipid molar fraction on the cytotoxic response of several human cell lines to DODAX : MO liposomes, and the ZET assay was performed to validate the results in vivo. Cellular metabolic activity, proliferation and plasma membrane integrity, induction of ROS accumulation, changes of the mitochondrial membrane potential, and cell death mechanisms (apoptosis versus necrosis) were evaluated in vitro. In the ZET protocol, zebrafish embryos were monitored via continuous waterborne exposure to DODAX : MO liposomes, for 80 hpf. The following endpoints were assessed: mortality, developmental delay signals, phenotypical malformations, spontaneous movements and freeswimming patterns, cardiac rhythm and hatching rate -using a "non-animal" (according to European Directive 2010/63/EU on the protection of animals used for scientific purposes) "intermediate" system, positioned amid cellular and mammal models. 24 We propose that a more complete and reliable approach to assess the effects of exposure to non-metallic particles should integrate both in vitro and in vivo parameters, suggesting the ZET assay as an informative platform for screening nanotoxicity effects.
Materials and methods

Chemicals and reagents
Dioctadecyldimethylammonium bromide (DODAB), dioctadecyldimethylammonium chloride (DODAC), and 1-monooleoyl-racglycerol (MO) were supplied by Sigma-Aldrich (Bornem, Belgium). DMEM® and M199® cell culture media, L-glutamine (L-Glu), Fetal Bovine Serum (FBS), trypsin-EDTA solution, Penicillin-Streptomycin (P/S) (5000 IU mL −1 penicillin and 5000 µg mL −1 streptomycin) and Hygromycin B® were purchased from Gibco (UK). The MTS assay kit was obtained from Promega (USA), and SRB solution was purchased from SigmaAldrich (USA). The Annexin-FITC kit was obtained from BD Biosciences (USA) and MitoTracker Red CMXRos from Molecular Probes (UK).
Preparation and biophysical characterization of liposomes
Liposomes were prepared by ethanolic injection. 25 Briefly, 2.3.3 Determination of cell proliferation by SRB assay. Cellular proliferation was determined by the sulphorhodamine B (SRB) assay after 8, 24 and 48 h contact with liposomes. Briefly, the medium was removed, cells were washed with phosphate-buffered saline (PBS) and a solution of 1% acetic acid in methanol was added to each well. After 1 h at −20°C, the wells were washed with PBS and dried, and 5% SRB solution (in 1% acetic acid) was added to each well. The microplates were incubated for 90 min at 37°C. After washing off the excess of SRB, 10 mM Tris was used to dissolve SRB, and absorbance was read at 540 nm using a multiplate reader (SpectraMax Plus 384, Molecular Devices). Timepoint 0 h (before addition of liposomes) was considered as 100% cell proliferation. The percentage of cell proliferation was expressed relative to non-treated cells (NT).
Evaluation of cell membrane integrity by LDH assay.
The lactate dehydrogenase (LDH) assay was used to determine cellular membrane integrity after 8, 24 and 48 h incubation with liposomes, as previously described. 25 The percentage of membrane integrity was expressed as a percentage of the intracellular LDH activity relative to the total (extracellular + intracellular) LDH activity. 
In vivo nanotoxicity assessment
All experiments were performed in compliance with the guidelines on the protection of experimental animals by the Council of Europe, Directive 86/609/EEC, which allows zebrafish embryos to be used up to the moment of free-living. As the ZET assays were carried out up to 80 hpf (i.e. within the regulatory limit of exposure, set at 120 hpf, which corresponds to the end of the embryonic development), no license is required.
2.4.1 ZET protocol and collected data. In vivo nanotoxicity and bioactivity of DODAX : MO liposomes were assessed with the zebrafish embryo toxicity (ZET) assay. 20 Fertilized eggs were randomly allocated into 24-well microplates (≈16-cell stadium, cleavage period; 5 eggs per mL), with continuous waterborne exposure to liposomes at different molar ratios (4 : 1, 2 : 1, 1 : 1, 1 : 2 and 1 : 4 mol : mol), for 80 hpf.
For each set of test conditions, all embryos were derived from the same eggs spawn. For experimental validation, viable eggs were obtained only from spawns with a > 90% fertilization rate. The individual and combined contribution of the nanoformulation components was screened (see Table 1 ). The (embryo)toxicity of ethanol (solvent of the lipids' stock solutions) and HEPES buffer (used to prepare the liposomes) was first investigated (ESI, Table S1 †) to set the toxicity limits for liposome production. Four replicates were considered for each condition, including experimental and solvent controls. The tested conditions were defined based on in vitro (nano) cytotoxicity profiles. The freshwater system was demonstrated not to affect the chorion and plasma membrane permeability of zebrafish embryos, enhancing their development and hatching rates more than high-calcium standard media, but common protozoan contamination is difficult to avoid. 27 Ultrapure water was used in all treatments to maintain zebrafish embryos mortality below 10%. To ensure optimal incubation temperature of the zebrafish embryos, all the test solutions and suspensions were pre-heated to 28 ± 1°C.
To analyze the effect of DODAX : MO liposome exposure on zebrafish embryos epiboly, the percentage of the epibolic arc at 8 hpf was estimated. This variable can provide an early warning signal of a developmental delay, given that at this embryonic stage the epibolic arc is known to correspond to 75% for the normal development of zebrafish. 28 The headtrunk angle (HTA) of 32 hpf zebrafish embryos was also measured in order to detect atypical development, given that this index was defined by Kimmel as a function of hours of development. 28 Additionally, 20 embryos from each treatment (10 per quadruplicates) were randomly selected and the number of heart beats was counted during 10 s. In order to avoid bias, "blind" observations were performed by a single person. At 8, 32, 56 and 80 hpf, 20 zebrafish embryos from each condition were photographed using a Leica DM IL LED inverted microscope coupled with an ICC50 HD camera. Measurements of the chorion, yolk, eye, pupil, head-trunk angle and body length (respective to each hpf ) were obtained using Image Tool (UTHSCSA, v3.00). The following morphological and physiological developmental endpoints were further assessed: mortality, developmental delay signals, phenotypical malformations, spontaneous movements and free-swimming patterns, cardiac rhythm and hatching rate. These variables were selected, given their potential implications in vital processes such as neuro-motor coordination. In all ZET experiments, dead embryos were removed to avoid cross-contamination, a process repeated three times every 24 h.
Results
Liposomes were found to have mean sizes <200 nm, a polydispersity index (PDI) < 0.5 and to be positively charged (>+50 mV), with no clear trend between formulations (ESI, Table S2 †). These characteristics were consistent with the formulations prepared using a similar methodology in previous studies. 25, 29 Nevertheless the structural organization of DODAX : MO liposomes is known to be dependent on the counter ion and MO molar fraction ( Fig. 1) : the reduced screening capacity of a Cl − ion when compared to a Br − ion results in a less ordered polar region for DODAC when compared to DODAB bilayers. These packing characteristics determine how MO is incorporated into the nanosystems: for high cationic lipid contents MO is homogeneously distributed into DODAC bilayers, while it forms DODAB-and MO-enriched domains in DODAB bilayers; when MO is in excess (molar fraction (1 : 2)), DODAB/DODAC-rich bilayers are formed, incorporating MO-rich inverted structures. 23 
DODAX : MO liposomes decrease cellular viability by more than one mechanism
To obtain a more holistic and integrated perspective on the possible adverse in vitro effects of liposomes, metabolic activity, cellular proliferation and plasma membrane integrity were assessed using immortalized normal human fibroblast cells (BJ5-ta) exposed for 8, 24 and 48 h to DODAX : MO liposomes (Fig. 2 ). Cells were exposed to 5, 20, 40, 80 and 160 µg mL 2) liposomes, and metabolic activity was determined by the MTS assay, cellular proliferation by the SRB assay and plasma membrane integrity by the LDH assay. For MTS, the percentage of metabolic activity was expressed relative to non-treated cells (NT), set to 100%; for SRB, timepoint 0 h (before addition of liposomes) was considered as 100% cell proliferation, and the percentage of cell proliferation was expressed relative to non-treated cells (NT); for LDH, the percentage of plasma membrane integrity was expressed as the percentage of intracellular LDH activity relative to the total (extracellular + intracellular) LDH activity. Results are expressed as mean ± S.E.M. of three independent experiments. DODAX : MO liposomes induced a concentration-and timedependent effect on fibroblast viability.
MTS results showed that the cytotoxic effects at the level of cellular metabolism become less evident with longer incubation times ( Fig. 2A versus 2B versus 2C) . In general, liposomal formulations with higher MO contents (B : M (1 : 2) and C : M (1 : 2)) caused lower cytotoxicity, supporting the notion that inclusion of MO, apart from improving efficiency, also enhances cytocompatibility. For the same molar fraction and after 48 h incubation, DODAC-were clearly more cytotoxic than DODAB-based formulations. For other timepoints, no clear trend was observed.
DODAX : MO negative effects on BJ5-ta proliferation, assessed by SRB, were only clearly visible for long exposure times (Fig. 2D versus 2E versus 2F) , with DODAC-based liposomes inducing a stronger negative effect on cell proliferation which was attenuated by the inclusion of MO in the formulation. Plasma membrane integrity evaluated by the LDH assay increased with increasing incubation time for all nanoformulations ( Fig. 2G-I) . After 8 and 24 h, this parameter was not compromised with up to 40 µg mL −1 liposomes, while after 48 h incubation with C : M (1 : 0) and C : M (2 : 1) resulted in a significant loss of plasma membrane integrity. The presence of MO also had a positive effect on the cytotoxicity, but only up to 40 µg mL −1 . In any case, B : M (1 : 2) prompted less disruptive effects on BJ5-ta plasma membranes and, for the same molar fraction, DODAC-based liposomes lead to more evident toxicity, at all exposure times. It also became evident that the effects of DODAX : MO liposomes on the metabolic activity, cellular proliferation and plasma membrane integrity were cell line-dependent (ESI, Induction of cell death after exposure of BJ5-ta to DODAX : MO liposomes was also assessed with the Annexin V/propidium iodide (PI) assay, in order to evaluate if different liposomal formulations induce the exposure of phosphatidylserine at the outer leaflet of the plasma membrane, a typical marker of apoptotic cells (Fig. 3) . Fig. 3 shows that, for the concentrations and timepoints tested, all DODAX : MO liposomes lead to an increase in the percentage of single (An+/PI−, early apoptotic cells; or An−/PI+, necrotic cells) and double stained cells (An+/PI+ late apoptotic cells), although almost no late apoptotic cells were detected. Overall, the contribution of the death mechanisms was very similar for all DODAX : MO liposomes, where the percentage of live cells (An−/PI−) increased from 24 to 48 h incubation with DODAX : MO liposomes (Fig. 3B versus 3D) (Fig. 3D ). Fig. 4 shows the accumulation of ROS by BJ5-ta cells after short exposure times (2, 4 and 8 h) to liposomes, chosen to limit massive cell death, and consequent reduced cell numbers, which would drive one to misleading conclusions. Fig. 4B) showed that, for the same molar fraction, DODAC-based liposomes led to higher ROS accumulation. Nevertheless, at 8 h, existence of cell death interfered with the ROS levels detected ( Fig. 2A and G) . It was interesting to notice that, not only did other cell lines (MDA-MB-468 and K562) produce less ROS after incubation with DODAX : MO liposomes, but also that their behavior did not follow the same trend as seen for BJ5-ta cells (ESI, Fig. S4 †) . This observation reinforces the notion that the effects are cell specific.
DODAX : MO liposomes trigger ROS accumulation and affect the mitochondrial membrane potential
Flow cytometry assays were performed in order to evaluate possible alterations in the mitochondrial membrane potential (ΔΨ m ) after incubation with DODAX : MO liposomes (Fig. 5) .
A drop in ΔΨ m generally occurred after incubation with liposomes for 24 and 48 h (Fig. 5 ), but this was only significantly different from NT cells after a 24 h exposure to C : M (2 : 1) liposomes.
In vivo evaluation of DODAX : MO liposomes toxicity using the ZET assay
When analyzing the effects of DODAX and MO, as free lipids or formulated in liposomes, on zebrafish embryos survival, a significant interaction was observed for DODAC (Fig. 6) .
In line with the data obtained with all in vitro experiments, DODAC showed higher embryotoxicity than DODAB, while MO did not cause any apparent toxicity. Moreover, after 8 hpf the overall survival of zebrafish embryos exposed to DODAC decreased in a concentration-dependent manner. The highest concentration (i.e. 9 µM of DODAC) led to 100% mortality of zebrafish eleutheroembryos (embryos post-hatch, but prior to external feeding). Interestingly, when mixed with MO, DODAC embryotoxicity was reduced, independently of the DODAC : MO ratio. Furthermore, the zebrafish embryos exposed to DODAX : MO liposomes, independently of the percentage of MO, showed survival rates ≥75%. These results are coherent with the cytotoxic profile obtained for in vitro cell-based tests. Table 2 summarizes the effect on the different parameters monitored during zebrafish embryogenesis (8-80 hpf ) upon exposure to different concentrations of the tested conditions, giving an overall and important perspective of the toxicity of single components, when in a mixture or in liposomal formulations.
Discussion
In this study we evaluated the effect of cationic liposomes' composition on the viability of several human cell lines, exploiting both the influence of the counter ion (Br ). Our aim was to obtain a comprehensive perspective of the toxicity profile of DODAX : MO liposomes and to understand how changing the lipid mixture influenced cells (metabolism, proliferation, cell death), tissues and organisms. Moreover, we set to highlight the potential of in vivo nanotoxicity assessment of liposomal nanocarriers in zebrafish embryotoxicity assays. These nanocarriers have been scarcely studied using these intermediate in vivo models, in stark contrast with metallic nanocarriers, in recent years.
Results obtained with the in vitro assays point to two general conclusions: DODAC-based liposomes induce higher cytotoxicity than DODAB-based liposomes, for the same molar fraction, in normal human fibroblasts; and the inclusion of MO in the formulation reduces cytotoxicity. Although the results were clearly cell-type dependent, the same trend was found for the other cellular models tested (293 T, MDA-MB-435, MDA-MB-468, K562 and THP1), in terms of metabolic activity and plasma membrane integrity (Fig. S1 and S3 †), but not for proliferation assessment (Fig. S2 †) . Interestingly, in vivo ZET assays showed that individual administration of DODAX (i.e. as free compounds) significantly disrupted fish development, with DODAC revealing a more toxic profile than DODAB, in a concentration-dependent manner. In contrast, DODAB or DODAC combined with MO in liposomes, in general, did not exert such level of toxicity. Moreover, the overall embryotoxicity profile of liposomes did not vary with the DODAX : MO molar fraction.
We have shown earlier that DODAC : MO and DODAB : MO have a different lipid structural organization due to the presence of the counter ions Cl − or Br − : MO is more homogeneously distributed in DODAC than in DODAB bilayers, which results in the formation of lamellar phases with less tight polar headgroups in DODAC : MO liposomes. 23 These characteristics may directly influence the different cytotoxic response observed for DODAC-and DODAB-based liposomes, as it is expectable an easier transference of DODAC to plasma membranes, promoting higher destabilization. In addition to having a less packed headgroup region, DODAC : MO liposomes also form smaller and more curved aggregates than DODABbased liposomes, 23, 35, 36 and are more fusogenic due to the more homogeneous MO incorporation. 23 ). MO's fusogenicity and capacity to increase the fluidity of the lipid bilayers 39 impelled us to further explore its influence on DODAX :
MO formulations when in interface with cells. Our results show that MO presence in the nanoformulation was generally beneficial for the cellular metabolism in all exposure times and for proliferation (48 h) of fibroblasts, with cell survival increasing in the order of DODAX : MO (1 : 0) < (2 : 1) < (1 : 2). observed by the slightly different response to DODAX : MO liposomes in the six cell lines tested. Therefore, it becomes evident that not only is the selection of the cell type very important for toxicity assessment, but also the integration of these results with data from in vivo models. An important consideration in ZET assays is the presence of the zebrafish chorion, an acellular envelope surrounding mature eggs of teleosts that enables for e.g. oxygen/carbon dioxide to pass through via passive diffusion. 45 The zebrafish chorion is composed of three intercrossed layers and possesses pores with approximately 0.5-0.7 µm diameter, 46 which should not impair the passage of the tested nanocarriers. In the present study, the clarification of specific and/or nonspecific interactions between dechorionation and nanotoxicity of DODAX : MO liposomes was not addressed. Nevertheless, our data showed that normal patterns of spontaneous movements and heart rhythm of 32 hfp zebrafish embryos varied with the DODAX : MO molar fraction. This differential effect allows one to anticipate that the toxicity of DODAX : MO liposomes was not conditioned by the presence of the chorion. On the other hand, the effect of zebrafish chorion removal has already been demonstrated with Luviquat HM 552, which blocks it due to the cationic polymer molecular weight (∼400 000 Da). 47 Interestingly, DODAX surfactants (with a higher molecular weight than Luviquat HM 552) were shown to affect multiple developmental variables of non-dechorionated zebrafish embryos/larvae, in a concentration-dependent manner. In agreement with the results from in vitro experiments, MO might favor the interaction of the cationic lipids with the chorion. Yet, the overall permeability contribution of the zebrafish chorion to the embryotoxicity of DODAX and MO, administered alone or combined in liposomal formulations, still needs to be confirmed. Since very high doses of DODAX : MO liposomes affected BJ5-ta cell metabolism, cellular proliferation and plasma membrane integrity, promoting cell death, we investigated if it was occurring through apoptosis or necrosis. Cationic liposomes might induce apoptosis, often after 24-48 h exposure, 9, 12, 48, 49 but they can also trigger acute cell necrosis, even before the occurrence of apoptosis, in a positive surface charge-dependent manner. 49 51 alterations on mitochondrial potential induced by DODAX : MO liposomes were evaluated. Although no significant effect was observed, our results suggest that DODAX : MO liposomes affected the mitochondrial membrane potential, especially after 24 h incubation with C : M (2 : 1). Future work will determine the zebrafish chorion permeability effects on embryonic ROS levels upon continuous waterborne exposure to DODAX : MO liposomes and free surfactants. The future of nanocarriers as therapeutic agents in medicine depends on the validation of multiparameter testing to account for the effects of administration routes, bioavailability, distribution and degradability, induction of developmental defects and activation of the complement and/or immune system. These factors are critical for in vivo nanotoxicity assessment and cannot be fully addressed with in vitro experiments. The integration of results from the in vitro and in vivo experiments will contribute to more comprehensive knowledge and allow predictions regarding the interaction of nanocarriers with cells, tissues and organisms. Zebrafish embryogenesis is an attractive and highly-informative in vivo model for fast track nanotoxicity assessment, bridging the gap between cellular trials and mammalian experiments 17, 24 and facilitating the translation of nanoformulations into a clinical setup.
Conclusions
Very high doses of DODAX : MO liposomes induce cytotoxicity in human fibroblasts, associated with cell death markers typical of apoptosis or necrosis, including exposure of phos-phatidylserine at the outer leaflet of the plasma membrane, accumulation of ROS, alteration of the mitochondrial membrane potential and plasma membrane disruption. The counter ion of the cationic lipid plays a determinant role in the elicited cytotoxicity: DODAC-based liposomes consistently induce more adverse effects, probably as a consequence of stronger cell membrane destabilization. All liposomal formulations have approximately the same size and surface charge, but the presence of MO promotes a general beneficial effect on cell survival, especially in the DODAB : MO mixture (1 : 2). Notably, an identical toxicity profile was obtained in vivo. Our results highlight the importance of a dose-dependent evaluation of the toxicity profile of liposomes, since different assays give different sensitivities to DODAX : MO. This concentration/ molar fraction dependency was demonstrated to be relevant to the embryotoxicity profile of DODAX and MO, either as free components or in liposome formulations. Five other cell lines give a consistent response to DODAX : MO liposomes in terms of cellular metabolism and plasma membrane integrity.
In vivo, the monitoring of the early life of zebrafish allows the detection of toxic signals induced by the different nanoformulations tested. The ZET assay reveals itself as highly appealing for application in "intermediate" nanotoxicity profiling, after initial screening in cultured cells and prior to validation in mammalian models.
